Safety Study of GNbAC1 in Multiple Sclerosis Patients

NCT01639300 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

BIOLOGICAL: GNbAC1
BIOLOGICAL: GNbAC1 placebo

Sponsor

GeNeuro Innovation SAS